Indian Immunologicals Ltd (IIL), a leading vaccine manufacturer in Asia, invests an estimated INR 700 Crore for setting up a greenfield veterinary vaccine manufacturing facility in Hyderabad. Dr K Anand Kumar, Managing Director, IIL, led the groundbreaking ceremony for the project on Thursday, December 28.
The greenfield facility will occupy an anticipated 14 Acres of land parcel in Phase III of TSIICL’s (Telangana State Industrial Infrastructure Corporation Ltd) Biotech Park at Karkapatta in Genome Valley. It will manufacture FMD-Vac (Foot and Mouth Disease Vaccine) and a combination of FMD+HS-Vac (Foot and Mouth Disease Vaccine and Haemorrhagic Septicaemia Vaccine).
Also Read: Upcoming Beachfront Residential Project – Prestige Ocean Pearl, Kozhikode
The project will have a generation capacity of 300 Million doses per year (150 Million doses of each vaccine) and will be equipped with a BSL-3 facility for manufacturing drugs. Moreover, it will also have a fill-finish capacity for producing drugs for the two vaccines. The project is anticipated to generate 750 direct and indirect job opportunities.
Biltrax Construction Data is tracking 28,000+ projects on their technology platform for their clients.
Get exclusive access to upcoming projects in India with actionable insights and gain a competitive advantage for your products in the Indian Construction Market.
Visit www.biltrax.com or email us at contact@biltrax.com to become a subscriber and generate leads.
Disclaimer: The information contained herein has been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. All such information and opinions can be subject to change. The image featured in this article is for representation purposes only and does not in any way represent the project. If you wish the article to be removed or edited, please email editor@biltrax.com.
0Discover more from Biltrax Media, A Biltrax Group venture
Subscribe to get the latest posts sent to your email.
